📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
37
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
47%
🔄 Reverse Split
55%
• 50-day avg $0.95 below $1 exchange minimum
🔁 Convertible Conversion
40%
• Significant convertible debt: 20% potential dilution
• Elevated convertible risk (60/100)
📉 Score Deterioration
40%
• Score rose 18 points recently (worsening)
💹 Market Data
Market Cap$164.69M
Shares Outstanding189.28M
Float135.48M
Cash$44.78M
Debt$141.63M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 7.8% shares (2025Q4 vs prior)
169 institutional holders · 157.81M shares
#1
Rubric Capital Management LP
30.05M shares
#2
Clearline Capital LP
12.24M shares
#3
ADAGE CAPITAL PARTNERS GP, L.L.C.
11.19M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest39.68M
Days to Cover14.0
% of Float29.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Dec 31, 2023
4
INSIDER TRANSACTION
Apr 06, 2026
4
INSIDER TRANSACTION
Feb 03, 2026
4
INSIDER TRANSACTION
Feb 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for HRTX
📊 HRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 HRTX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.